immune-mediated diseases – Talk Bio

Actionable Insights Powered by AI

Tolerance Bio Secures $17.2M Seed Funding to Develop Thymus-Targeted Cell Therapies

6 months ago talkbio0Tagged Allogeneic, Bio, Cell Therapy, Drug Tolerance, immune-mediated diseases, Plant seeds, thymus extracts

Tolerance Bio, cell therapy, thymus, immune-mediated diseases, seed funding, allogeneic iPSC-based therapy

Alumis Files for IPO to Fund Phase 3 Studies for Second-Generation TYK2 Inhibitor

11 months ago talkbio0Tagged Alumis, immune-mediated diseases, Immunology, Inhibitor, IPO, Phase 3 studies, Precision - temporal, TYK2, TYK2 gene

Alumis, IPO, TYK2 inhibitor, Phase 3 studies, immune-mediated diseases, biotech, precision immunology